Search details
1.
Identification of novel differentially expressed genes in type 1 diabetes mellitus complications using transcriptomic profiling of UAE patients: a multicenter study.
Sci Rep
; 12(1): 16316, 2022 09 29.
Article
in English
| MEDLINE | ID: mdl-36175575
2.
Diabetes and Ramadan: Practical guidelines 2021.
Diabetes Res Clin Pract
; 185: 109185, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35016991
3.
Amenorrhoea with XY karyotype postbone marrow transplant.
BMJ Case Rep
; 14(2)2021 Feb 05.
Article
in English
| MEDLINE | ID: mdl-33547101
4.
Biometric and metabolic changes in patients with diabetes prior, during and after the holy month of Ramadan (ABCD Study).
Diabetes Res Clin Pract
; 173: 108678, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33516783
5.
Evaluation of optimum diabetes care on glycemic control of patients with gestational diabetes during Ramadan fasting.
Diabetes Res Clin Pract
; 173: 108669, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33460717
6.
A systematic review on the safety of Ramadan fasting in high-risk patients with Diabetes.
Diabetes Res Clin Pract
; 164: 108161, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32335095
7.
Differential Expression of Inflammatory Markers in Hypoglycemia Unawareness Associated with Type 1 Diabetes: A Case Report.
Brain Sci
; 11(1)2020 Dec 25.
Article
in English
| MEDLINE | ID: mdl-33375551
8.
Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
Diabetes Res Clin Pract
; 169: 108466, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32971155
9.
A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting.
Diabetes Metab Syndr
; 13(2): 1413-1429, 2019.
Article
in English
| MEDLINE | ID: mdl-31336501
10.
Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases.
Diabetol Metab Syndr
; 11: 80, 2019.
Article
in English
| MEDLINE | ID: mdl-31572499
11.
Should metformin still be the first-line of treatment in type 2 diabetes mellitus? A comprehensive review and suggested algorithm.
Diabetes Metab Syndr
; 13(3): 1935-1942, 2019.
Article
in English
| MEDLINE | ID: mdl-31235118
12.
Lipid Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in Dubai: A Five-year Pattern.
Oman Med J
; 34(4): 290-296, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31360316
13.
Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes.
Diabetes Metab Syndr
; 13(5): 2927-2932, 2019.
Article
in English
| MEDLINE | ID: mdl-31425958
14.
Glycemic and lipids control in patients with diabetes and cardiovascular or renal diseases across all the government health sectors in the Emirate of Dubai, United Arab Emirates.
Diabetes Metab Syndr
; 13(1): 590-594, 2019.
Article
in English
| MEDLINE | ID: mdl-30641771
15.
The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
Diabetes Res Clin Pract
; 151: 305-312, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30880094
16.
Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre flash continuous glucose monitor (FSL-CGMS).
Diabetes Res Clin Pract
; 150: 308-314, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30771364
17.
Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy.
Diabetes Res Clin Pract
; 150: 301-307, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30768940
18.
Glycemic Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year Pattern.
Oman Med J
; 34(1): 20-25, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30671180
19.
The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes.
Diabetes Res Clin Pract
; 150: 288-295, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30641167
20.
SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.
J Clin Med Res
; 10(8): 615-625, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29977418